Global Stable Isotope Labeled Compounds Market– Industry Trends and Forecast to 2025
The Stable Isotope Labeled Compounds market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Global Stable Isotope Labeled Compounds Market is expected to reach USD 321.27 million by 2025, from USD 254.6 billion in 2017 growing at a CAGR of 2.9% during the forecast period of 2018 to 2025. Get Free Sample of This Information Analysis:http://databridgemarketresearch.com/request-asample/?dbmr=global-stable-isotope-labeled-compounds-market
Cambridge Isotope Laboratories, Inc. (CIL), leading supplier of stable isotopes and stable isotopeenriched small molecules across the world, is functioning together with Nexomics Biosciences, a structural biology and protein production contract research organization. They together are working to provide isotope-labeled proteins to life science research organizations. In 2006, Shimadzu (subsidiary of Shimadzu Asia Pacific Pte Ltd) acquired France-based AlsaChim, a specialist for high-quality analytical isotope labeled standards. This acquisition will increase Shimadzu’s business in the clinical and diagnostic market, but also in other market segments of stable isotope labeled compounds. Some of the major players operating in the global stable isotope labeled compounds market are
CambridgeIsotope Laboratories, Inc.
13 C Molecular
3M
C D N Isotopes Inc.
Isoflex
Merck KGaA
Urenco Limited
Isosciences, LLC
Medical Isotopes, Inc.
Los Alamos National Laboratory
Others: Omicron Biochemicals, Inc., Nordion (Canada) Inc., Trace Sciences International, Isosciences, Alsachim, JSC Isotope, Taiyo Nippon Sanso Corporation, Perkinelmer Inc. and Rotem